| Literature DB >> 36012538 |
Ping Hu1, Enhua Hao2, Zhende Yang1, Zhisong Qiu1, Hengfei Fu1, Jintao Lu1, Ziting He1, Yingqi Huang1.
Abstract
Endoclita signifer larvae show olfactory recognition towards volatiles of eucalyptus trunks and humus soils. Further, EsigGOBP1 was identified through larval head transcriptome and speculated as the main odorant-binding proteins in E. signifer larvae. In this study, the highest expression of EsigGOBP1 was only expressed in the heads of 3rd instar larvae of E. signifer, compared with the thorax and abdomen; this was consistent with the phenomenon of habitat transfer of 3rd instar larvae, indicating that EsigGOBP1 was a key OBP gene in E. signifer larvae. Results of fluorescence competition binding assays (FCBA) showed that EsigGOBP1 had high binding affinities to eight GC-EAD active ligands. Furthermore, screening of key active odorants for EsigGOBP1 and molecular docking analysis, indicated that EsigGOBP1 showed high binding activity to alpha-phellandrene in 3rd instar larvae of E. signifer. Conformational analysis of the EsigGOBP1-alpha-phellandrene complex, showed that MET49 and GLU38 were the key sites involved in binding. These results demonstrated that EsigGOBP1 is a key odorant-binding protein in E. signifer larvae, which recognizes and transports eight key volatiles from eucalyptus trunk, especially the main eucalyptus trunks volatile, alpha-phellandrene. Taken together, our results showed that EsigGOBP1 is involved in host selection of E. signifer larvae, which would aid in developing EsigGOBP1 as molecular targets for controlling pests at the larval stage.Entities:
Keywords: eucalyptus; general odorant-binding proteins; molecular docking; qRT-PCR
Mesh:
Substances:
Year: 2022 PMID: 36012538 PMCID: PMC9409361 DOI: 10.3390/ijms23169269
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 6.208
Figure 1Expression profile of EsigGOBP1 in E. signifer larvae from exposure to key volatiles. (A) 3rd instar larvae; (B) 5th instar larvae. The standard errors are represented by the error bars, * and ** above the bars denote significant differences at p < 0.05 and p < 0.001 respectively.
Figure 2Sequence and structure of EsigGOBP1. (A) Three-dimensional structure of EsigGOBP1; (B) Alignment of EsigGOBP1 with 3D structures of GOBPs in insect and AmelOBP2. The six a-helices with black boxes are as follows, Ala18–Glu23(α1a), Ile26-Ile33 (α1b), Glu40–Lys46 (α2), Lys69–Lys82 (α3), Leu94–Asp103 (α4), Arg108–Asn125 (α5), and Asn140–Glu157 (α6); the red boxes refer to signal peptide; the * refer to six conserved cysteines. The structure was predicted using the SWISS MODEL online tools (http://swissmodel.expasy.org/, accessed on 27 May 2022) and based on Helicoverpa armigera pheromone-binding protein PBP1 at pH 7.5 (PDB ID: 7vw8.1.A).
Figure 3Fluorescence competitive binding assay of EsigGOBP1. (A) The binding curve and Scatchard analysis of EsigGOBP1 and 1-NPN.
Binding of different compounds to recombinant GOBP1 of E. signifer.
| EsigGOBP1 | |||
|---|---|---|---|
| Ligands | IC50 (µM) | Ki (µM) | Binding Energy (kcal/mol) |
| Camphene | 7.870 | 0.988 | −5.21 |
| Eucalyptol | 10.130 | 1.272 | −4.26 |
| Benzene, 1,2-diethyl- | 6.305 | 0.792 | −4.11 |
| alpha-Pinene | 9.860 | 1.238 | −4.54 |
| β-Pinene | 10.520 | 1.321 | −4.55 |
| alpha-Phellandrene | 7.080 | 0.889 | −5.00 |
| n-Butyl ether | 9.400 | 1.180 | −3.56 |
| D-limonene | 11.410 | 1.433 | −4.79 |
| Butyl acrylate | 7.180 | 0.901 | −3.57 |
| 1,3,5-trimethyl-benzen | 36.658 | 4.602 | −4.12 |
| Naphthalene | 21.454 | 2.694 | −4.57 |
| 2-Phenyl-2-propanol | 22.024 | 2.765 | −3.98 |
Figure 4Molecular docking index of the EsigGOBP1–alpha-phellandrene complex. The root-mean-square deviation (RMSD) values for carbon backbones of the EsigGOBP1–alpha-phellandrene complex during the 40 ns molecular dynamics (MD) simulations (A); Residue fluctuations for the EsigGOBP1–alpha-phellandrene complex during the 40 ns MD simulations (B); Canonical conformations of the EsigGOBP1-alpha-phellandrene complex. (C) Interactions in the EsigGOBP1-alpha-phellandrene complex (D).